This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Catalym Gmbh, Julius-Maximilians-Universitat Wurzburg. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 54 
Years Active: 2025
Title: Eugen Leo: Innovator in Cancer Treatment
Introduction
Eugen Leo is a notable inventor based in München, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Eugen Leo holds a patent for an "ANTI-GDF15 ANTIBODY AND A DOSAGE REGIMEN FOR THE TREATMENT OF CANCER." This patent represents a crucial advancement in therapeutic options for cancer patients.
Career Highlights
Throughout his career, Eugen Leo has worked with prestigious institutions, including Julius-Maximilians-Universität Würzburg and Catalym GmbH. His work in these organizations has been instrumental in advancing cancer research and treatment methodologies.
Collaborations
Eugen has collaborated with esteemed colleagues such as Markus Haake and Jörg Wischhusen. Their combined expertise has contributed to the success of various projects in the realm of cancer therapy.
Conclusion
Eugen Leo's innovative work and dedication to cancer treatment exemplify the impact of research and invention in the medical field. His contributions continue to inspire advancements in therapeutic strategies for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile